Based on the most recent data, HIMS has returned 155.8% so far this year. Meanwhile, the Medical sector has returned an average of 6.8% on a year-to-date basis. This shows that Hims & Hers Health, Inc. is outperforming its peers so far this year. In TransMedics' case, the consensus EPS estimate for the current year increased 701.9% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Another stock in the Medical sector, TransMedics (TMDX) , has outperformed the sector so far this year. ...